Back to Search Start Over

LBA4 The efficacy and safety of TQ-B2450 alone/with anlotinib in previously treated advanced non-small cell lung cancer (NSCLC): A multicenter, randomized, double-blind, placebo-controlled clinical trial.

Authors :
Han, B.
Li, K.
Wang, Q.
Cheng, Y.
Yang, L.
Li, Y.
Source :
Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1429-S1429. 1p.
Publication Year :
2021

Details

Language :
English
ISSN :
09237534
Volume :
32
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
153829499
Full Text :
https://doi.org/10.1016/j.annonc.2021.10.219